应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02126 药明巨诺-B
已收盘 10-02 16:08:34
2.060
+0.210
+11.35%
最高
2.200
最低
1.940
成交量
724.09万
今开
2.030
昨收
1.850
日振幅
14.05%
总市值
8.55亿
流通市值
8.55亿
总股本
4.15亿
成交额
1,499万
换手率
1.74%
流通股本
4.15亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
药明巨诺-B10月02日遭主力抛售103万元 环比增加110.20%
市场透视 · 51分钟前
药明巨诺-B10月02日遭主力抛售103万元 环比增加110.20%
药明巨诺-B盘中异动 早盘急速上涨8.11%
市场透视 · 09:32
药明巨诺-B盘中异动 早盘急速上涨8.11%
港股生物技术股持续走强,康宁杰瑞制药(09966.HK)大涨32%,药明巨诺(02126.HK)大涨12%,科济药业(02171.
美港电讯 · 09-30 10:30
港股生物技术股持续走强,康宁杰瑞制药(09966.HK)大涨32%,药明巨诺(02126.HK)大涨12%,科济药业(02171.
药明巨诺-B(02126)上涨10.13%,报1.74元/股
金融界 · 09-30 10:27
药明巨诺-B(02126)上涨10.13%,报1.74元/股
药明巨诺-B盘中异动 早盘股价大涨8.86%
市场透视 · 09-30 09:31
药明巨诺-B盘中异动 早盘股价大涨8.86%
药明巨诺-B(02126)上涨7.3%,报1.47元/股
金融界 · 09-27
药明巨诺-B(02126)上涨7.3%,报1.47元/股
药明巨诺-B盘中异动 股价大涨5.84%
市场透视 · 09-27
药明巨诺-B盘中异动 股价大涨5.84%
药明巨诺-B(02126)下跌5.11%,报1.3元/股
金融界 · 09-23
药明巨诺-B(02126)下跌5.11%,报1.3元/股
港股生物技术股多数下跌,永泰生物-B(06978.HK)、思路迪医药股份(01244.HK)跌超10%,药明巨诺-B(02126.
美港电讯 · 09-23
港股生物技术股多数下跌,永泰生物-B(06978.HK)、思路迪医药股份(01244.HK)跌超10%,药明巨诺-B(02126.
药明巨诺-B盘中异动 股价大跌5.11%报1.300港元
市场透视 · 09-23
药明巨诺-B盘中异动 股价大跌5.11%报1.300港元
药明巨诺-B(02126)上涨10.48%,报1.37元/股
金融界 · 09-20
药明巨诺-B(02126)上涨10.48%,报1.37元/股
港股生物医药股集体走高,北海康成-B涨超13%
老虎资讯综合 · 09-20
港股生物医药股集体走高,北海康成-B涨超13%
东曜药业-B盘中异动 早盘大幅下挫5.00%
市场透视 · 09-20
东曜药业-B盘中异动 早盘大幅下挫5.00%
药明巨诺-B盘中异动 大幅拉升5.65%报1.310港元
市场透视 · 09-20
药明巨诺-B盘中异动 大幅拉升5.65%报1.310港元
港股午评:恒指早盘高开高走 贵金属、生物医药板块强势
美港电讯 · 09-13
港股午评:恒指早盘高开高走 贵金属、生物医药板块强势
药明巨诺-B(02126)股价上升5.042%,现价港币$1.25
阿斯达克财经 · 09-12
药明巨诺-B(02126)股价上升5.042%,现价港币$1.25
药明巨诺-B(02126)股价上升7.087%,现价港币$1.36
阿斯达克财经 · 09-05
药明巨诺-B(02126)股价上升7.087%,现价港币$1.36
药明巨诺-B授出合共203.91万份购股权及合共66.96万个受限制股份单位
新浪网 · 09-03
药明巨诺-B授出合共203.91万份购股权及合共66.96万个受限制股份单位
药明巨诺-B(02126)授出合共203.91万份购股权及合共66.96万个受限制股份单位
智通财经 · 09-02
药明巨诺-B(02126)授出合共203.91万份购股权及合共66.96万个受限制股份单位
药明巨诺-B(02126)委任陈炳钧为独立非执行董事
智通财经网 · 08-28
药明巨诺-B(02126)委任陈炳钧为独立非执行董事
暂无数据
公司概况
公司名称:
药明巨诺-B
所属市场:
SEHK
上市日期:
--
主营业务:
药明巨诺(开曼)有限公司是一家主要从事临床及临床前阶段细胞治疗的中国公司。该公司致力于为中国市场开发细胞治疗手段,为中国癌症患者带来新兴治疗方式。通过其子公司,其建立了一个专注为血液癌症及实体瘤开发、制造和商业化突破性细胞免疫疗法的一体化平台。其主打候选产品relmacabtagene autoleucel(relma-cel)是针对复发或难治(r/r)B细胞淋巴瘤的自体抗CD19 CAR-T疗法。该公司主要于中国市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02126","market":"HK","secType":"STK","nameCN":"药明巨诺-B","latestPrice":2.06,"timestamp":1727856514031,"preClose":1.85,"halted":0,"volume":7240934,"delay":0,"floatShares":415170078,"shares":415170078,"eps":-2.062575,"marketStatus":"已收盘","marketStatusCode":5,"change":0.21,"latestTime":"10-02 16:08:34","open":2.03,"high":2.2,"low":1.94,"amount":14985980,"amplitude":0.140541,"askPrice":2.08,"askSize":5000,"bidPrice":2.06,"bidSize":45500,"shortable":0,"etf":0,"ttmEps":-1.6821882576542297,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1727919000000},"adr":0,"listingDate":1604332800000,"adjPreClose":1.85,"openAndCloseTimeList":[[1727832600000,1727841600000],[1727845200000,1727856000000]],"volumeRatio":2.475731,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02126/tweets","defaultTab":"tweets","newsList":[{"id":"2472164175","title":"药明巨诺-B10月02日遭主力抛售103万元 环比增加110.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472164175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472164175?lang=zh_cn&edition=full","pubTime":"2024-10-02 16:16","pubTimestamp":1727857010,"startTime":"0","endTime":"0","summary":"10月02日, 药明巨诺-B股价涨11.35%,报收2.06元,成交金额1498万元,换手率1.74%,振幅14.05%,量比2.47。药明巨诺-B今日主力资金净流出103万元,连续3日净流出,上一交易日主力净流出49万元,今日环比增加110.20%。该股近5个交易日上涨49.28%,主力资金累计净流出209万元;近20日主力资金累计净流出180万元,其中净流出天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410021618209f24c916&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410021618209f24c916&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","02126","BK1574"],"gpt_icon":0},{"id":"2472655776","title":"药明巨诺-B盘中异动 早盘急速上涨8.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472655776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472655776?lang=zh_cn&edition=full","pubTime":"2024-10-02 09:32","pubTimestamp":1727832736,"startTime":"0","endTime":"0","summary":"2024年10月02日早盘09时32分,药明巨诺-B股票出现异动,股价急速上涨8.11%。药明巨诺-B股票所在的生物技术行业中,整体跌幅为1.15%。其相关个股中,贝康医疗-B、药明巨诺-B、维亚生物涨幅较大,振幅较大的相关个股有贝康医疗-B、泰格医药、基石药业-B,振幅分别为8.41%、7.73%、7.18%。药明巨诺-B公司简介:药明巨诺(开曼)有限公司是一家主要从事细胞免疫治疗产品的研究及开发、生产及上市的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002093216ab67622e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002093216ab67622e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1583","BK1161","BK1574"],"gpt_icon":0},{"id":"2471811182","title":"港股生物技术股持续走强,康宁杰瑞制药(09966.HK)大涨32%,药明巨诺(02126.HK)大涨12%,科济药业(02171.","url":"https://stock-news.laohu8.com/highlight/detail?id=2471811182","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471811182?lang=zh_cn&edition=full","pubTime":"2024-09-30 10:30","pubTimestamp":1727663458,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1141","LU0456846285.SGD","LU0052750758.USD","HSTECH","LU0307460666.USD","02171","BK1191","LU0043850808.USD","LU0181495838.USD","YANG","BK1161","BK0239","BK1587","BK1574","BK1576","LU0051755006.USD","LU0359201612.USD","LU0979878070.USD","LU0140636845.USD","LU1794554557.SGD","LU0039217434.USD","LU0856984785.SGD","BK1589","02126","LU0819121731.USD","LU0516423091.SGD","SG9999002463.SGD","LU0708995583.HKD","LU0359202008.SGD","09966","LU0516422366.SGD","LU0516423174.USD","LU0823426308.USD","LU0456827905.SGD","LU1242518931.SGD","BK1610","07226","LU0320764599.SGD","LU0417516738.SGD","HSCEI","LU1242518857.USD","688428","BK1583","LU0588546209.SGD","LU1880383366.USD","BK1521","09969","LU0327786744.USD","02269","06185"],"gpt_icon":0},{"id":"2471446811","title":"药明巨诺-B(02126)上涨10.13%,报1.74元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2471446811","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471446811?lang=zh_cn&edition=full","pubTime":"2024-09-30 10:27","pubTimestamp":1727663248,"startTime":"0","endTime":"0","summary":"9月30日,药明巨诺-B(02126)盘中上涨10.13%,截至10:27,报1.74元/股,成交332.68万元。药明巨诺是一家专注于开发、生产和商业化细胞免疫治疗产品的创新型生物科技公司,目标是成为细胞免疫治疗领域的领导者。公司自2016年成立以来,已建立了涵盖血液肿瘤、实体肿瘤和自身免疫性疾病的细胞免疫治疗产品管线,并致力于用创新的、高品质的产品帮助全球患者得到治愈。截至2024年中报,药明巨诺-B营业总收入8681.5万元、净利润-2.4亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/30102743642437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02126","BK1161","BK1574","BK1583"],"gpt_icon":0},{"id":"2471818462","title":"药明巨诺-B盘中异动 早盘股价大涨8.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471818462","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471818462?lang=zh_cn&edition=full","pubTime":"2024-09-30 09:31","pubTimestamp":1727659910,"startTime":"0","endTime":"0","summary":"2024年09月30日早盘09时31分,药明巨诺-B股票出现异动,股价急速上涨8.86%。截至发稿,该股报1.720港元/股,成交量8.75万股,换手率0.02%,振幅3.16%。药明巨诺-B股票所在的生物技术行业中,整体涨幅为1.45%。药明巨诺-B公司简介:药明巨诺(开曼)有限公司是一家主要从事细胞免疫治疗产品的研究及开发、生产及上市的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930093154ab66e803&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930093154ab66e803&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","02126","BK1161"],"gpt_icon":0},{"id":"2470748340","title":"药明巨诺-B(02126)上涨7.3%,报1.47元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2470748340","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470748340?lang=zh_cn&edition=full","pubTime":"2024-09-27 10:34","pubTimestamp":1727404456,"startTime":"0","endTime":"0","summary":"9月27日,药明巨诺-B(02126)盘中上涨7.3%,截至10:34,报1.47元/股,成交124.55万元。药明巨诺是一家专注于开发、生产和商业化细胞免疫治疗产品的创新型生物科技公司,目标是成为细胞免疫治疗领域的领导者。公司自2016年成立以来,已建立了涵盖血液肿瘤、实体肿瘤和自身免疫性疾病的细胞免疫治疗产品管线,并致力于用创新的、高品质的产品帮助全球患者得到治愈。截至2024年中报,药明巨诺-B营业总收入8681.5万元、净利润-2.4亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/27103443562393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK1583","BK1574","02126"],"gpt_icon":0},{"id":"2470710073","title":"药明巨诺-B盘中异动 股价大涨5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470710073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470710073?lang=zh_cn&edition=full","pubTime":"2024-09-27 10:01","pubTimestamp":1727402471,"startTime":"0","endTime":"0","summary":"2024年09月27日早盘10时01分,药明巨诺-B股票出现异动,股价快速拉升5.84%。截至发稿,该股报1.450港元/股,成交量50.85万股,换手率0.12%,振幅5.84%。药明巨诺-B股票所在的生物技术行业中,整体涨幅为1.42%。药明巨诺-B公司简介:药明巨诺(开曼)有限公司是一家主要从事细胞免疫治疗产品的研究及开发、生产及上市的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927100115a1dce113&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927100115a1dce113&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02126","BK1583"],"gpt_icon":0},{"id":"2469257152","title":"药明巨诺-B(02126)下跌5.11%,报1.3元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2469257152","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469257152?lang=zh_cn&edition=full","pubTime":"2024-09-23 14:17","pubTimestamp":1727072272,"startTime":"0","endTime":"0","summary":"9月23日,药明巨诺-B(02126)盘中下跌5.11%,截至14:17,报1.3元/股,成交110.58万元。药明巨诺是一家专注于开发、生产和商业化细胞免疫治疗产品的创新型生物科技公司,目标是成为细胞免疫治疗领域的领导者。公司自2016年成立以来,已建立了涵盖血液肿瘤、实体肿瘤和自身免疫性疾病的细胞免疫治疗产品管线,并致力于用创新的、高品质的产品帮助全球患者得到治愈。截至2024年中报,药明巨诺-B营业总收入8681.5万元、净利润-2.4亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/23141743414429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02126","BK1161","BK1574","BK1583"],"gpt_icon":0},{"id":"2469156441","title":"港股生物技术股多数下跌,永泰生物-B(06978.HK)、思路迪医药股份(01244.HK)跌超10%,药明巨诺-B(02126.","url":"https://stock-news.laohu8.com/highlight/detail?id=2469156441","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469156441?lang=zh_cn&edition=full","pubTime":"2024-09-23 13:07","pubTimestamp":1727068027,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1720050803.USD","LU0181495838.USD","LU0052750758.USD","LU0516422366.SGD","LU0417516902.SGD","06127","BK1161","LU0359201612.USD","BK1521","LU0039217434.USD","HSCEI","LU0516422440.USD","LU0456846285.SGD","LU0320764599.SGD","LU0516423091.SGD","07226","HSTECH","LU0979878070.USD","02269","LU0051755006.USD","LU1242518857.USD","LU0348825331.USD","BK1589","LU0516423174.USD","LU0708995583.HKD","LU0588546209.SGD","YANG","LU0819121731.USD","BK1141","LU0856984785.SGD","BK1576","LU0417516738.SGD","01244","LU0327786744.USD","LU1794554557.SGD","LU0326950275.SGD","LU1688375341.USD","LU0140636845.USD","LU0572944931.SGD","IE00B0JY6N72.USD","SG9999002463.SGD","BK1583","LU0307460666.USD","02126","LU0456827905.SGD","BK0216","LU0516422952.EUR","LU1242518931.SGD","603127","06978"],"gpt_icon":0},{"id":"2469131187","title":"药明巨诺-B盘中异动 股价大跌5.11%报1.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469131187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469131187?lang=zh_cn&edition=full","pubTime":"2024-09-23 10:16","pubTimestamp":1727057819,"startTime":"0","endTime":"0","summary":"2024年09月23日早盘10时16分,药明巨诺-B股票出现波动,股价快速下跌5.11%。截至发稿,该股报1.300港元/股,成交量27.8719万股,换手率0.07%,振幅8.03%。资金方面,该股资金流入7.367万港元,流出25.9585万港元。药明巨诺-B股票所在的生物技术行业中,整体跌幅为0.28%。其相关个股中,帝王国际投资、瑞科生物-B、再鼎医药涨幅较大,振幅较大的相关个股有创胜集团-B、科济药业-B、永泰生物-B,振幅分别为14.42%、11.76%、10.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923101659ab653c2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923101659ab653c2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1161","BK1583","BK1574"],"gpt_icon":1},{"id":"2468927966","title":"药明巨诺-B(02126)上涨10.48%,报1.37元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2468927966","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468927966?lang=zh_cn&edition=full","pubTime":"2024-09-20 15:38","pubTimestamp":1726817888,"startTime":"0","endTime":"0","summary":"9月20日,药明巨诺-B(02126)盘中上涨10.48%,截至15:38,报1.37元/股,成交140.72万元。药明巨诺是一家专注于开发、生产和商业化细胞免疫治疗产品的创新型生物科技公司,目标是成为细胞免疫治疗领域的领导者。公司自2016年成立以来,已建立了涵盖血液肿瘤、实体肿瘤和自身免疫性疾病的细胞免疫治疗产品管线,并致力于用创新的、高品质的产品帮助全球患者得到治愈。截至2024年中报,药明巨诺-B营业总收入8681.5万元、净利润-2.4亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/20153843375816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","02126","BK1161","BK1583"],"gpt_icon":0},{"id":"1127201658","title":"港股生物医药股集体走高,北海康成-B涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127201658","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127201658?lang=zh_cn&edition=full","pubTime":"2024-09-20 10:00","pubTimestamp":1726797632,"startTime":"0","endTime":"0","summary":"9月20日,港股生物医药股集体走高,$北海康成-B(01228)$涨超13%,$药明巨诺-B(02126)$涨超7%,$来凯医药-B(02105)$、$创胜集团-B(06628)$涨超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02126","BK1574","HSTECH","02105","06628","01228","BK1583","HSCEI","07226","YANG","BK1161"],"gpt_icon":0},{"id":"2468654982","title":"东曜药业-B盘中异动 早盘大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468654982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468654982?lang=zh_cn&edition=full","pubTime":"2024-09-20 09:46","pubTimestamp":1726796799,"startTime":"0","endTime":"0","summary":"2024年09月20日早盘09时46分,东曜药业-B股票出现异动,股价急速下跌5.00%。截至发稿,该股报1.900港元/股,成交量1.6万股,换手率0.00%,振幅5.00%。东曜药业-B股票所在的生物技术行业中,整体涨幅为0.22%。其相关个股中,北海康成-B、药明巨诺-B、创胜集团-B涨幅较大,振幅较大的相关个股有正大企业国际、药明巨诺-B、宜明昂科-B,振幅分别为11.25%、6.45%、6.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409200946399719bef2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409200946399719bef2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01875","02126","BK1161","BK1574","BK1583","06628"],"gpt_icon":0},{"id":"2468651460","title":"药明巨诺-B盘中异动 大幅拉升5.65%报1.310港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468651460","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468651460?lang=zh_cn&edition=full","pubTime":"2024-09-20 09:35","pubTimestamp":1726796149,"startTime":"0","endTime":"0","summary":"2024年09月20日早盘09时35分,药明巨诺-B股票出现波动,股价大幅上涨5.65%。截至发稿,该股报1.310港元/股,成交量2.2万股,换手率0.01%,振幅4.03%。资金方面,该股资金流入2.409万港元,流出2645港元。药明巨诺-B股票所在的生物技术行业中,整体涨幅为0.01%。其相关个股中,药明巨诺-B、乐普生物-B、科笛-B涨幅较大,振幅较大的相关个股有宜明昂科-B、乐普生物-B、科伦博泰生物-B,振幅分别为6.02%、4.44%、4.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920093549a1db4ef1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920093549a1db4ef1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","02126","BK1161"],"gpt_icon":0},{"id":"2467793934","title":"港股午评:恒指早盘高开高走 贵金属、生物医药板块强势","url":"https://stock-news.laohu8.com/highlight/detail?id=2467793934","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467793934?lang=zh_cn&edition=full","pubTime":"2024-09-13 12:06","pubTimestamp":1726200398,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["513600","MCHmain","02359","GLD","HSImain","DUST","HHImain","161726","BK0012","00168","MGCmain","09926","SGUmain","LU2495084118.USD","LU0197773160.USD","HSCEI","LU0417516571.SGD","159831","BK0188","02899","BK1505","LU1997245094.SGD","BK0187","603259","GCmain","07226","02126","LU0197773673.USD","159934","518880","GDX","LU1997245177.USD","YANG","HSTECH","01876","600547","02833","01787","01818","SGCmain","LU0463099449.HKD","LU0345780281.USD","LU1997244956.HKD","HSI","399441","IAU","601899","NUGT","MHImain"],"gpt_icon":0},{"id":"2466216749","title":"药明巨诺-B(02126)股价上升5.042%,现价港币$1.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2466216749","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466216749?lang=zh_cn&edition=full","pubTime":"2024-09-12 11:40","pubTimestamp":1726112400,"startTime":"0","endTime":"0","summary":"[上升股]药明巨诺-B(02126) 股价在上午11:40比前收市价上升5.042%,现股价为港币$1.25。至目前为止,今日最高价为$1.25,而最低价为$1.19。总成交量为10.4万股,总成交金额为港币$12.592万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2409121981/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02126","BK1161","BK1574","BK1583"],"gpt_icon":0},{"id":"2465151371","title":"药明巨诺-B(02126)股价上升7.087%,现价港币$1.36","url":"https://stock-news.laohu8.com/highlight/detail?id=2465151371","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465151371?lang=zh_cn&edition=full","pubTime":"2024-09-05 14:26","pubTimestamp":1725517560,"startTime":"0","endTime":"0","summary":"[上升股]药明巨诺-B(02126) 股价在下午02:26比前收市价上升7.087%,现股价为港币$1.36。至目前为止,今日最高价为$1.36,而最低价为$1.23。总成交量为22.35万股,总成交金额为港币$28.365万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240905958/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1583","02126","BK1161"],"gpt_icon":0},{"id":"2464423892","title":"药明巨诺-B授出合共203.91万份购股权及合共66.96万个受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2464423892","media":"新浪网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464423892?lang=zh_cn&edition=full","pubTime":"2024-09-03 08:46","pubTimestamp":1725324387,"startTime":"0","endTime":"0","summary":"药明巨诺-B发布公告,于2024年9月2日,根据2020年10月14日采纳的公司首次公开发售后激励计划的条款将合共203.91万份购股权;及根据2020年10月14日采纳的公司首次公开发售后受限制股份单位计划将合共66.96万个受限制股份单位,授予两名承授人。【免责声明】本文仅代表作者本人观点,与和讯网无关。和讯网站对文中陈述、观点判断保持中立,不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考,并请自行承担全部责任。邮箱:news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024090309042495dd5f10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024090309042495dd5f10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","02126","BK1161"],"gpt_icon":0},{"id":"2464183315","title":"药明巨诺-B(02126)授出合共203.91万份购股权及合共66.96万个受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2464183315","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464183315?lang=zh_cn&edition=full","pubTime":"2024-09-02 19:31","pubTimestamp":1725276702,"startTime":"0","endTime":"0","summary":"智通财经APP讯,药明巨诺-B(02126)发布公告,于2024年9月2日,根据2020年10月14日采纳的公司首次公开发售后激励计划的条款将合共203.91万份购股权;及根据2020年10月14日采纳的公司首次公开发售后受限制股份单位计划将合共66.96万个受限制股份单位,授予两名承授人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1178276.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1574","02126","BK1161"],"gpt_icon":0},{"id":"2462451023","title":"药明巨诺-B(02126)委任陈炳钧为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2462451023","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462451023?lang=zh_cn&edition=full","pubTime":"2024-08-28 19:52","pubTimestamp":1724845970,"startTime":"0","endTime":"0","summary":"药明巨诺-B(02126)公布,陈炳钧已获委任为独立非执行董事,自2024年8月2...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_9.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_9.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1173604.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02126","BK1161","BK1574","BK1583"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.4231},{"period":"1month","weight":0.3806},{"period":"3month","weight":-0.0212},{"period":"6month","weight":-0.016},{"period":"1year","weight":-0.1063},{"period":"ytd","weight":-0.1814}],"compareEarnings":[{"period":"1week","weight":0.1582},{"period":"1month","weight":0.1748},{"period":"3month","weight":0.1893},{"period":"6month","weight":0.2636},{"period":"1year","weight":0.1866},{"period":"ytd","weight":0.2397}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明巨诺(开曼)有限公司是一家主要从事临床及临床前阶段细胞治疗的中国公司。该公司致力于为中国市场开发细胞治疗手段,为中国癌症患者带来新兴治疗方式。通过其子公司,其建立了一个专注为血液癌症及实体瘤开发、制造和商业化突破性细胞免疫疗法的一体化平台。其主打候选产品relmacabtagene autoleucel(relma-cel)是针对复发或难治(r/r)B细胞淋巴瘤的自体抗CD19 CAR-T疗法。该公司主要于中国市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.01079},{"month":2,"riseRate":0.75,"avgChangeRate":0.067143},{"month":3,"riseRate":0,"avgChangeRate":-0.17939},{"month":4,"riseRate":0.25,"avgChangeRate":-0.041215},{"month":5,"riseRate":0.5,"avgChangeRate":0.022518},{"month":6,"riseRate":0.25,"avgChangeRate":-0.080401},{"month":7,"riseRate":0.25,"avgChangeRate":-0.08945},{"month":8,"riseRate":0,"avgChangeRate":-0.178563},{"month":9,"riseRate":0.25,"avgChangeRate":-0.070933},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.041718},{"month":11,"riseRate":0.666667,"avgChangeRate":0.315863},{"month":12,"riseRate":0.75,"avgChangeRate":-0.039996}],"exchange":"SEHK","name":"药明巨诺-B","nameEN":"JW THERAP-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明巨诺-B(02126)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明巨诺-B(02126)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明巨诺-B,02126,药明巨诺-B股票,药明巨诺-B股票老虎,药明巨诺-B股票老虎国际,药明巨诺-B行情,药明巨诺-B股票行情,药明巨诺-B股价,药明巨诺-B股市,药明巨诺-B股票价格,药明巨诺-B股票交易,药明巨诺-B股票购买,药明巨诺-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明巨诺-B(02126)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明巨诺-B(02126)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}